There are very few people who are willing to discuss the pending mega merger between American publically traded agro biotech company Monsanto, and the German megalithic life science and pharma company Bayer. The deal is worth a reported $66 billion and has unsurprisingly piqued the interest of antitrust agencies across the world.
May 29 2018